FDA Inspection 1162922 — Bioiberica, SAU
The FDA completed an inspection of Bioiberica, SAU on February 4, 2022 in Palafolls. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- February 4, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Palafolls (Spain)